Funder: Florida Department of Health
Due Dates (Anticipated): September 2027 (Letter of Intent) | October 2027 (Application)
Funding Amounts: Category maximums of $100,000–$1,500,000, including direct and indirect costs, for up to 6–48 months
Summary: Supports Florida cancer research, clinical trials, equipment, and infrastructure to advance cures and reduce cancer disparities.
Key Information: The designated PI must be an applicant employee and a U.S. citizen or permanent resident.
Description
The Bankhead-Coley Cancer Research Program is administered by the Florida Department of Health’s Biomedical Research Section, with advice from the Biomedical Research Advisory Council (BRAC). It awards competitive, peer-reviewed grants to expand Florida’s cancer research capacity, improve research and treatment through clinical trial networks, and reduce cancer’s impact on disproportionately affected groups.
Supported work includes prevention and treatment, screening, obesity and cancer, treatment-related morbidities, technology-transfer feasibility, and development of Investigational New Drug or Investigational Device Exemption applications. The program also supports research infrastructure and equipment. Priorities include reducing morbidity and mortality, improving screening accuracy, addressing resistance to front-line treatments in recurrent disease, and strengthening collaborations among institutions, researchers, and community practitioners.
